AlzChem Financial Statements From 2010 to 2024
| ACT Stock | EUR 57.80 0.40 0.70% |
Check AlzChem Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AlzChem Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . AlzChem financial statements analysis is a perfect complement when working with AlzChem Group Valuation or Volatility modules.
AlzChem |
AlzChem Group AG Company EBITDA Analysis
AlzChem Group's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current AlzChem Group EBITDA | 62.69 M |
Most of AlzChem Group's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AlzChem Group AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, AlzChem Group AG reported earnings before interest,tax, depreciation and amortization of 62.69 M. This is much higher than that of the sector and significantly higher than that of the EBITDA industry. The ebitda for all Germany stocks is notably lower than that of the firm.
AlzChem Group AG Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining AlzChem Group's current stock value. Our valuation model uses many indicators to compare AlzChem Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AlzChem Group competition to find correlations between indicators driving AlzChem Group's intrinsic value. More Info.AlzChem Group AG is rated fifth in current valuation category among its peers. It is rated second in price to book category among its peers . The ratio of Current Valuation to Price To Book for AlzChem Group AG is about 193,568,809 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AlzChem Group's earnings, one of the primary drivers of an investment's value.About AlzChem Group Financial Statements
AlzChem Group shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although AlzChem Group investors may analyze each financial statement separately, they are all interrelated. The changes in AlzChem Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on AlzChem Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for AlzChem Stock Analysis
When running AlzChem Group's price analysis, check to measure AlzChem Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzChem Group is operating at the current time. Most of AlzChem Group's value examination focuses on studying past and present price action to predict the probability of AlzChem Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzChem Group's price. Additionally, you may evaluate how the addition of AlzChem Group to your portfolios can decrease your overall portfolio volatility.